Suggestions
Piet Hein van Dam
CEO and founder at Clear.
Piet Hein van Dam is a seasoned entrepreneur and CEO/founder of Clear.bio, a healthtech startup based in Amsterdam.14 He has a strong background in health technology and data, with a PhD in physical chemistry from the University of Amsterdam.2
Van Dam's career spans various sectors, including:
- Started at Unilever in functional foods
- Worked as a strategy consultant at KPMG
- Served as CEO of Motivaction, a Dutch market research agency
- Built data-driven startups in AdTech, MediaTech, HRTech, and FinTech2
Clear.bio, founded in 2019, focuses on helping people with type 2 diabetes improve their health through personalized nutrition advice and real-time glucose monitoring.14 The company uses advanced technology, including AI and IoT, to provide actionable insights for better food choices.3
Key achievements and recognitions:
- Two successful exits from previous ventures1
- Winner of the Unilever R&D Golden Jubilee Award
- Selected in the TOP 50 Global HealthTech CEOs of 20222
- Holds 6 patents2
Van Dam is known for his high IQ, EQ, and execution quotient (XQ), with Gallup Signature Strengths in adaptability, inclusion, belief, strategic thinking, and activation.4 He is also a TEDx speaker, trainer, lecturer, and author.5
Highlights
Clear.bio just received the #globalexcellence award as a #globalleader in #datadriven diabetic nutrition by the Acquisition International Magazine.
Nice achievement team!
We are helping patients to revert diabetes 2 within 3 months, with a treatment that is reimbursed and costs only a few 100 euros. About the same as your mobile phone subscription. Each cured patient saves him/her a lifelong journey of medication and saves the taxpayer several 1000's of euros per annum in health care costs. This is how technology helps to fight the global tsunami of chronic diseases - at scale. We have treated over 6000 patients sofar. Saved consequently €20-30 mio in healthcare costs. A nice ROI.
#precisionnutrition #diabetesreversal
Clear.bio is participating next week at the Advanced Technologies & Treatments for Diabetes (ATTD) conference in #firenze.
We're presenting the long term results of our digital diabetes treatment, with a smart app, a real coach and interment use of a cgm. E-POSTER VIEWING: AS05 with Madelon Bracke.
We're also open to discuss #fundraising #clinicalresearch #collaboration #healthcare #insuranceinnovation #precisionnutrition #diabetesreversal #globalexpansion #cgm #sensorsolutions
Ping me for a coffee ☕
